Inhibition of Endopeptidase‐24.15 Decreases Blood Pressure in Normotensive Rats

No abstract is available for this paper.

• Publication year

  1991

• Venue

  HYPERTENSION

• Publication date

  1991-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1161/01.HYP.18.3.360PMID 1889849
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interaction of ANP and bradykinin during endopeptidase 24.11 inhibition: renal effects.

  1990cited by this paper
• Role of Angiotensin Converting Enzyme and Other Peptidases in In Vivo Metabolism of Kinins

  1989cited by this paper
• Inhibition of endopeptidase 24.15 slows the in vivo degradation of luteinizing hormone-releasing hormone.

  1989cited by this paper
• SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats.

  1989cited by this paper
• Effects of UK 69 578: a novel atriopeptidase inhibitor.

  1989cited by this paper
• Contributions of various rat plasma peptidases to kinin hydrolysis.

  1989cited by this paper
• Degradation of Atrial Natriuretic Peptide: Pharmacologic Effects of Protease EC 24.11 Inhibition

  1989cited by this paper
• Enkephalin is liberated from metorphamide and dynorphin A1-8 by endo-oligopeptidase A, but not by metalloendopeptidase EC 3.4.24.15.

  1988cited by this paper
• Effect of a kinin antagonist on the acute antihypertensive activity of enalaprilat in severe hypertension.

  1988cited by this paper
• 56 SCH‐39370, an inhibitor of neutral metalloendopeptidase potentiates the biological actions and plasma levels of immunoreactive atrial natriuretic factor and lowers blood pressure in the deoxycorticosterone hypertensive rat

  1988cited by this paper
• Contribution of bradykinin to maintenance of blood pressure and renal blood flow in anaesthetized spontaneously hypertensive rats

  1988cited by this paper
• Substrate-related potent inhibitors of brain metalloendopeptidase.

  1988cited by this paper
• Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo.

  1987cited by this paper
• Regulatory peptide metabolism at cell surfaces: the key role of endopeptidase-24.11.

  1986cited by this paper
• Vasodepressor role of endogenous bradykinin assessed by a bradykinin antagonist.

  1986cited by this paper
• Regulatory peptide metabolism at cell surfaces: the key role of endopeptidase-24.11.

  1986cited by this paper
• Soluble metalloendopeptidase from rat brain: action on enkephalin-containing peptides and other bioactive peptides.

  1985influential reference
• Competitive antagonists of bradykinin.

  1985cited by this paper
• A computer-assisted technique for analysis and comparison of dose-response curves.

  1984cited by this paper
• The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase-24.11.

  1984cited by this paper
• A soluble metalloendopeptidase from rat brain. Purification of the enzyme and determination of specificity with synthetic and natural peptides.

  1983cited by this paper
• A soluble metalloendopeptidase from rat brain

  1983cited by this paper
• Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421.

  1982cited by this paper
• Role of Kinins in the Acute Antihypertensive Effect of the Converting Enzyme Inhibitor, Captopril

  1981cited by this paper
• Pharmacology of bradykinin and related kinins.

  1980cited by this paper
• Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme.

  1977cited by this paper
• PULMONARY METABOLISM OF BRADYKININ ANALOGUES AND THE CONTRIBUTION OF ANGIOTENSIN CONVERTING ENZYME TO BRADYKININ INACTIVATION IN ISOLATED LUNGS

  1977cited by this paper
• Isolation of brain endopeptidases: influence of size and sequence of substrates structurally related to bradykinin.

  1976cited by this paper
• Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.

  1976cited by this paper
• An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients.

  1974cited by this paper
• Preparation, assay, and partial characterization of a neutral endopeptidase from rabbit brain.

  1973cited by this paper
• A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin.

  1970cited by this paper
• The Effect of the Kinins on the Cardiovascular System

  1970cited by this paper
• Second Kininase in Human Blood Plasma

  1967cited by this paper
• Effects of synthetic bradykinin on the cardiovascular system.

  1965cited by this paper
• EFFECT OF DRUG INFUSION ON THE SYSTEMIC AND SPLANCHNIC CIRCULATION. I. BRADYKININ INFUSION IN NORMAL SUBJECTS.

  1964cited by this paper
• Bradykinin and cardiovascular system: estimation of half-life.

  1962cited by this paper

• Increased Stability of Oligopeptidases Immobilized on Gold Nanoparticles

  2020cites this paper
• Human matrix metalloproteinases: an ubiquitarian class of enzymes involved in several pathological processes.

  2012cites this paper
• STRUCTURAL BASIS OF SUBSTRATE RECOGNITION IN THIMET OLIGOPEPTIDASE AND DEVELOPMENT OF NANOPARTICLES FOR THERAPEUTIC ENZYME DELIVERY

  2012cites this paper
• Metabolism of Bradykinin by Peptidases in Health and Disease

  2007cites this paper
• STRUCTURAL AND FUNCTIONAL STUDIES OF SYNAPTIC ENZYMES

  2006cites this paper
• Hemodynamic regulation of metalloendopeptidases EC3.4; 24.15 and EC3.4; 24.16: expression and function in the vascular endothelium

  2005cites this paper
• Prologue: kinins and related systems. New life for old discoveries.

  2003cites this paper
• Soluble metalloendopeptidases and neuroendocrine signaling.

  2002influential citation
• Modulation of incipient glomerular lesions in experimental diabetic nephropathy by hypotensive and subhypotensive dosages of an ACE inhibitor.

  2001cites this paper
• Metalloendopeptidases EC 3.4.24.15 and EC 3.4.24.16 And Bradykinin B2 Receptors Do Not Play Important Roles In Renal Wrap Hypertension In Rabbits

  2001cites this paper
• A novel stable inhibitor of endopeptidases EC 3.4.24.15 and 3.4.24.16 potentiates bradykinin-induced hypotension.

  2000cites this paper
• Release of angiotensin-(1-7) from the rat hindlimb: influence of angiotensin-converting enzyme inhibition.

  2000cites this paper
• Development and characterization of novel potent and stable inhibitors of endopeptidase EC 3.4.24.15.

  2000cites this paper
• Soluble neutral metallopeptidases: physiological regulators of peptide action

  2000cites this paper
• Effects of aminopeptidase P inhibition on kinin-mediated vasodepressor responses.

  1999cites this paper
• Effects of aminopeptidase P inhibition on kinin-mediated vasodepressor responses

  1999cites this paper
• Local renin-angiotensin system is involved in K+-induced aldosterone secretion from human adrenocortical NCI-H295 cells.

  1999cites this paper
• Promoter sequence of rat thimet oligopeptidase.

  1998cites this paper
• Biphasic effect of bradykinin on rabbit afferent arterioles.

  1998cites this paper
• Section Review Cardiovascular & Renal: Bradykinin degradation: potential pathways for cardiovascular therapeutic use

  1996cites this paper
• Endopeptidase inhibitors decrease myocardial ischemia/reperfusion injury in an in vivo rabbit model.

  1996cites this paper
• Synthetic inhibitors of endopeptidase EC 3.4.24.15: potency and stability in vitro and in vivo

  1996cites this paper
• Significance of renal kininases in patients with primary aldosteronism.

  1995cites this paper
• Development of Highly Potent and Selective Phosphinic Peptide Inhibitors of Zinc Endopeptidase 24-15 Using Combinatorial Chemistry (*)

  1995cites this paper
• ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS AND KININ METABOLISM: EVIDENCE THAT ACE INHIBITORS MAY INHIBIT A KININASE OTHER THAN ACE

  1995cites this paper
• Role of angiotensin converting enzyme in the vascular effects of an endopeptidase 24.15 inhibitor

  1995cites this paper
• Characterization of an endooligopeptidase A‐like protein in PC12 cells: Activity modulation by cAMP but not by basic fibroblast growth factor

  1995cites this paper
• Neuropeptidases: candidate enzymes and techniques for study.

  1994cites this paper
• Effects of a Metalloendopeptidase‐24.15 Inhibitor on Renal Hemodynamics and Function in Rats

  1994cites this paper
• Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.

  1994cites this paper
• Endopeptidase 3.4.24.11 converts N-1-(R,S)carboxy-3-phenylpropyl-Ala-Ala-Phe-p-carboxyanilide into a potent inhibitor of angiotensin-converting enzyme.

  1993cites this paper
• Evidence that enzymatic conversion of N-[1(R,S)-carboxy-3-phenylpropyl]-Ala-Ala-Phe-p-aminobenzoate, a specific inhibitor of endopeptidase 24.15, to N-[1(R,S)-carboxy-3-phenylpropyl]-Ala-Ala is necessary for inhibition of angiotensin converting enzyme.

  1993cites this paper
• Modulatory effect of endopeptidase inhibitors on bradykinin-induced contraction of rat uterus.

  1993cites this paper
• Thimet oligopeptidase--a review of a thiol dependent metallo-endopeptidase also known as Pz-peptidase endopeptidase 24.15 and endo-oligopeptidase.

  1993cites this paper
• Receptor antagonists of bradykinin: a new tool to study the cardiovascular effects of endogenous kinins.

  1993cites this paper
• Renal Kininase I, Kininase II and Neutral Endopeptidase 24.11 Activities in Patients with Essential Hypertension, Primary Aldosteronism and Cushing's Syndrome

  1993cites this paper
• Biological Roles of Angiotensin-(1-7).

  1992cites this paper
• Inhibitors of some recently characterized kinin-metabolizing enzymes: a brief overview.

  1992cites this paper
• Structural and functional studies of the metalloendopeptidase (EC 3.4.24.15) involved in degrading gonadotropin releasing hormone.

  1992cites this paper
• Inhibitors of some recently characterized kinin-metabolizing enzymes: a brief overview.

  1992cites this paper
• Effects of Hoe 140, a bradykinin B2‐receptor antagonist, on renal function in conscious normotensive rats

  1992cites this paper
• Inhibition of angiotensin converting enzyme by the metalloendopeptidase 3.4.24.15 inhibitor c-phenylpropyl-alanyl-alanyl-phenylalanyl-p-aminobenzoate.

  1992cites this paper
• Hypertension in the elderly with a special focus on treatment with angiotensin-converting enzyme inhibitors and calcium antagonists.

  1992cites this paper
• Local Hormonal Factors (Intracrine, Autocrine, and Paracrine) in Hypertension

  1991cites this paper
• Zinc Metallopeptidase Inhibitors A Novel Antihypertensive Treatment

  1991cites this paper
• Chapter 9. Endogenous Vasoactive Peptides

  1990cites this paper
• Comment Zinc Metallopeptidase Inhibitors A Novel Antihypertensive Treatment

  year unknowncites this paper